Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Sargent

Showing results (11-20 of 295) with videos related to

Pageof 30
Sort By:
JAMA Oncology|June 9, 2016
Adjuvant Therapy for Colon Cancer: Small Steps Toward Precision MedicineAxel Grothey, Daniel J Sargent
The New England Journal of Medicine|July 1, 2005
Adjuvant therapy for colon cancer--the pace quickensCarmen Allegra, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Assessing the measure of a new drug: is survival the only thing that matters?Daniel J Sargent, Daniel F Hayes
Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Clinical trials data collection: when less is moreDaniel J Sargent, Stephen L George
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need?Christopher H Crane, Daniel J Sargent
Clinical Trials (London, England)|April 16, 2010
Predictive biomarker validation in practice: lessons from real trialsSumithra J Mandrekar, Daniel J Sargent
Genome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J Sargent
Current Opinion in Oncology|May 16, 2009
Clinical implications of microsatellite instability in sporadic colon cancersFrank A Sinicrope, Daniel J Sargent
Clinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J Mandrekar
Pageof 30

Showing results (11-20 of 295) with videos related to

Sort By:
Pageof 30
JAMA Oncology|June 9, 2016
Adjuvant Therapy for Colon Cancer: Small Steps Toward Precision MedicineAxel Grothey, Daniel J Sargent
The New England Journal of Medicine|July 1, 2005
Adjuvant therapy for colon cancer--the pace quickensCarmen Allegra, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Assessing the measure of a new drug: is survival the only thing that matters?Daniel J Sargent, Daniel F Hayes
Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Clinical trials data collection: when less is moreDaniel J Sargent, Stephen L George
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need?Christopher H Crane, Daniel J Sargent
Clinical Trials (London, England)|April 16, 2010
Predictive biomarker validation in practice: lessons from real trialsSumithra J Mandrekar, Daniel J Sargent
Genome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J Sargent
Current Opinion in Oncology|May 16, 2009
Clinical implications of microsatellite instability in sporadic colon cancersFrank A Sinicrope, Daniel J Sargent
Clinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J Mandrekar
Pageof 30